📊 AI Stock Rating — Summary

Health Realty's Q3 2025 reported revenue was $297.8 million with a net loss of $57.7 million, translating to an EPS of -$0.17. Free cash flow was notably $268.5 million despite a capital expenditure of $154.8 million. The net margin was negative, indicating challenges in turning revenue into profit. Year-over-year growth data is not provided, but the current metrics suggest some operational inefficiencies. The company has a substantial amount of net debt at approximately $4.68 billion and paid $84.8 million in dividends over the past year. Share buybacks are minimal. Analysts provide price targets ranging from $19 to $23, implying potential appreciation from current levels.

AI Score Breakdown

Revenue Growth — Score: 4/10

The latest data shows a revenue of $297.8 million, but without prior year's data, growth cannot be assessed. Current revenue figures do not indicate significant expansion, suggesting stagnation or modest growth.

Profitability — Score: 3/10

Operating efficiency is weak with a net loss of $57.7 million and negative EPS of -$0.17, indicating troubleshooting in converting sales into profit.

Cash Flow Quality — Score: 6/10

Free cash flow was positive at $268.5 million, highlighting strong cash generation capacity. However, reliance on this without concrete profitability may not be sustainable long-term.

Leverage & Balance Sheet — Score: 4/10

Net debt is significant at $4.68 billion, which raises concerns over financial resilience despite an equity base of $4.74 billion.

Shareholder Returns — Score: 5/10

Dividends were robust at $84.8 million. Share buybacks were negligible. Without 1-year price change data, shareholder return relies heavily on dividends.

Analyst Sentiment & Valuation — Score: 5/10

The P/E and FCF yield details were missing, making it tough to evaluate valuation thoroughly. Price targets up to $23 suggest potential upside from the valuation date.

⚠ AI-generated — informational only, not financial advice.